SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-008220
Filing Date
2014-11-14
Accepted
2014-11-14 15:08:42
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0914_biopharmx.htm 10-Q 331002
2 CERTIFICATION ex31.htm EX-31 11464
3 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, ex32.htm EX-32.1 4021
  Complete submission text file 0001213900-14-008220.txt   3020476

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bpmx-20140930.xml EX-101.INS 372080
5 XBRL SCHEMA FILE bpmx-20140930.xsd EX-101.SCH 25417
6 XBRL CALCULATION FILE bpmx-20140930_cal.xml EX-101.CAL 32399
7 XBRL DEFINITION FILE bpmx-20140930_def.xml EX-101.DEF 94585
8 XBRL LABEL FILE bpmx-20140930_lab.xml EX-101.LAB 241863
9 XBRL PRESENTATION FILE bpmx-20140930_pre.xml EX-101.PRE 179262
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54871 | Film No.: 141223348
SIC: 1700 Construction - Special Trade Contractors